170
- Know | 8~22℃, major progress! China Biotech’s second-generation recombinant protein new crown vaccine was approved for clinical use! Daxing District received a report of a positive nucleic acid, and the main activity track was announced! China
- CanSino Biologics: New Crown mRNA Vaccine Receives Drug Clinical Trial Approval from China Food and Drug Administration | Duowei News | China Multidimensional News Network
- CSPC and CanSino’s new crown mRNA vaccine approved for clinical trials in China, stock prices soar Wall Street Journal
- New vaccine clinical trials were approved intensively over the weekend!CanSino, CSPC mRNA vaccine, and China Biopharmaceutical second-generation recombinant protein vaccine were approved for clinical use Wall Street News
- CanSino Biologics: New Coronavirus mRNA Vaccine Receives Drug Clinical Trial Approval from the State Food and Drug Administration-IT & Health cnBeta
- See full coverage on Google News